Subscribe to RSS

DOI: 10.1055/a-2363-0905
Deep invasive mucinous adenocarcinoma without surface amorphous pattern on inflammatory bowel disease: specific disease with specific characterization
Authors
Endoscopic characterization of deep invasive carcinoma using current classifications (CONECCT III, JNET III, NICE III) is effective but was not developed for neoplasias associated with inflammatory bowel diseases (IBDs). In IBD, dysplastic lesions often present as flat, non-granular laterally spreading tumors (LST-NGs) [1] [2]. However, mucosal distortion caused by chronic inflammation and regenerative changes can conceal dysplasia, making the detection and characterization of the colonic lesions challenging [3] [4]. The present case illustrates that deep invasive adenocarcinoma can occur with very slight mucosal changes in an IBD lesion ([Video 1]).
Invasive adenocarcinoma in inflammatory bowel disease lesion with slight mucosal changes.Video 1A 53-year-old woman was referred for endoscopic resection of a 15-mm IBD-related sigmoid lesion (previously diagnosed with high grade dysplasia on biopsy). The lesion was classified as LST-NG with a single and delineated area exhibiting a disorganized pattern ([Fig. 1]). Endoscopic submucosal dissection (ESD) was indicated to ensure en bloc resection, and an adaptative traction strategy with A-TRACT was employed due to an expected strong fibrosis. The dissection phase proceeded smoothly until reaching the center of the lesion, where a pool of mucus emerged and spread out within the submucosal region. The procedure ended without adverse events facilitated by the use of an adaptative traction device and an underwater strategy during the dissection. The histopathology revealed an adenocarcinoma with submucosal invasion (R1 vertical margins and high risk features) and a mucinous lake within the lesion ([Fig. 2]).




It can be inferred that the whitish cloudy appearance in the submucosa may signal the presence of a mucinous component, implying a deeply invasive lesion with high risk features such as mucinous submucosal invasion. Consequently, it is frequently linked with a non-curative resection and could lead to stopping the dissection during the procedure. The challenge in characterizing IBD lesions should prompt the utilization of progressively advanced endoscopic technologies and techniques to ensure en bloc resection with an accurate histological evaluation.
Endoscopy_UCTN_Code_TTT_1AO_2AG_3AD
E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy.
All papers include a high-quality video and are published with a Creative Commons
CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission
process. We grant 100% waivers to articles whose corresponding authors are based in
Group A countries and 50% waivers to those who are based in Group B countries as classified
by Research4Life (see: https://www.research4life.org/access/eligibility/).
This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.
Conflict of Interest
Jérôme Rivory, Jean Grimaldi, Louis Jean Masgnaux, Mathieu Pioche are co-founders of the ATRACT devices and co. Nothing to declare for the other authors.
-
References
- 1 Sugimoto S, Naganuma M, Iwao Y. et al. Endoscopic morphological features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc 2017; 85: 639-646
- 2 Laine L, Kaltenbach T, Barkun A. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015; 81: 639-651
- 3 Rutter MD, Saunders BP, Schofield G. et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260
- 4 Vinsard DG, Bruining DH, East JE. et al. Interobserver agreement of modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc 2023; 97: 790-798
Correspondence
Publication History
Article published online:
29 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Sugimoto S, Naganuma M, Iwao Y. et al. Endoscopic morphological features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc 2017; 85: 639-646
- 2 Laine L, Kaltenbach T, Barkun A. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015; 81: 639-651
- 3 Rutter MD, Saunders BP, Schofield G. et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260
- 4 Vinsard DG, Bruining DH, East JE. et al. Interobserver agreement of modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc 2023; 97: 790-798




